115 related articles for article (PubMed ID: 38394536)
1. The investigation of cytotoxic and apoptotic activity of Cl-amidine on the human U-87 MG glioma cell line.
Öğüten PN; Engür Öztürk S; Dikmen M
Medicine (Baltimore); 2024 Feb; 103(8):e37015. PubMed ID: 38394536
[TBL] [Abstract][Full Text] [Related]
2. Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme.
Kosgodage US; Uysal-Onganer P; MacLatchy A; Kraev I; Chatterton NP; Nicholas AP; Inal JM; Lange S
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597867
[TBL] [Abstract][Full Text] [Related]
3. N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.
Willis VC; Gizinski AM; Banda NK; Causey CP; Knuckley B; Cordova KN; Luo Y; Levitt B; Glogowska M; Chandra P; Kulik L; Robinson WH; Arend WP; Thompson PR; Holers VM
J Immunol; 2011 Apr; 186(7):4396-404. PubMed ID: 21346230
[TBL] [Abstract][Full Text] [Related]
4. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor.
Chumanevich AA; Causey CP; Knuckley BA; Jones JE; Poudyal D; Chumanevich AP; Davis T; Matesic LE; Thompson PR; Hofseth LJ
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G929-38. PubMed ID: 21415415
[TBL] [Abstract][Full Text] [Related]
5. The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.
Causey CP; Jones JE; Slack JL; Kamei D; Jones LE; Subramanian V; Knuckley B; Ebrahimi P; Chumanevich AA; Luo Y; Hashimoto H; Sato M; Hofseth LJ; Thompson PR
J Med Chem; 2011 Oct; 54(19):6919-35. PubMed ID: 21882827
[TBL] [Abstract][Full Text] [Related]
6. Molecular targeting of protein arginine deiminases to suppress colitis and prevent colon cancer.
Witalison EE; Cui X; Causey CP; Thompson PR; Hofseth LJ
Oncotarget; 2015 Nov; 6(34):36053-62. PubMed ID: 26440311
[TBL] [Abstract][Full Text] [Related]
7. Controlled Delivery of Pan-PAD-Inhibitor Cl-Amidine Using Poly(3-Hydroxybutyrate) Microspheres.
Ahmed D; Puthussery H; Basnett P; Knowles JC; Lange S; Roy I
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884657
[TBL] [Abstract][Full Text] [Related]
8. The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest.
Cui X; Witalison EE; Chumanevich AP; Chumanevich AA; Poudyal D; Subramanian V; Schetter AJ; Harris CC; Thompson PR; Hofseth LJ
PLoS One; 2013; 8(1):e53791. PubMed ID: 23308284
[TBL] [Abstract][Full Text] [Related]
9. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
Mondal S; Thompson PR
Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
[TBL] [Abstract][Full Text] [Related]
10. Peptidylarginine Deiminase Inhibitor Cl-Amidine Attenuates Cornification and Interferes with the Regulation of Autophagy in Reconstructed Human Epidermis.
Cau L; Takahara H; Thompson PR; Serre G; Méchin MC; Simon M
J Invest Dermatol; 2019 Sep; 139(9):1889-1897.e4. PubMed ID: 30878672
[TBL] [Abstract][Full Text] [Related]
11. Lauryl Gallate Induces Apoptotic Cell Death through Caspase-dependent Pathway in U87 Human Glioblastoma Cells
Liu CC; Lin WW; Wu CC; Hsu SL; Wang CY; Chung JG; Chiang CS
In Vivo; 2018; 32(5):1119-1127. PubMed ID: 30150434
[TBL] [Abstract][Full Text] [Related]
12. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
[TBL] [Abstract][Full Text] [Related]
13. Investigation of cytotoxic antiproliferative and antiapoptotic effects of nanosized boron phosphate filled sodium alginate composite on glioblastoma cancer cells.
Poyraz FS; Ugraskan V; Mansuroglu B; Yazici O
Mol Biol Rep; 2023 Dec; 50(12):10257-10270. PubMed ID: 37934369
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of collagen-induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses.
Kawalkowska J; Quirke AM; Ghari F; Davis S; Subramanian V; Thompson PR; Williams RO; Fischer R; La Thangue NB; Venables PJ
Sci Rep; 2016 May; 6():26430. PubMed ID: 27210478
[TBL] [Abstract][Full Text] [Related]
15. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.
Martín Monreal MT; Rebak AS; Massarenti L; Mondal S; Šenolt L; Ødum N; Nielsen ML; Thompson PR; Nielsen CH; Damgaard D
Front Immunol; 2021; 12():716250. PubMed ID: 34737738
[TBL] [Abstract][Full Text] [Related]
16. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
17. BB-Cl-Amidine as a novel therapeutic for canine and feline mammary cancer via activation of the endoplasmic reticulum stress pathway.
Ledet MM; Anderson R; Harman R; Muth A; Thompson PR; Coonrod SA; Van de Walle GR
BMC Cancer; 2018 Apr; 18(1):412. PubMed ID: 29649984
[TBL] [Abstract][Full Text] [Related]
18. Development and use of clickable activity based protein profiling agents for protein arginine deiminase 4.
Slack JL; Causey CP; Luo Y; Thompson PR
ACS Chem Biol; 2011 May; 6(5):466-76. PubMed ID: 21265574
[TBL] [Abstract][Full Text] [Related]
19. Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
McElwee JL; Mohanan S; Griffith OL; Breuer HC; Anguish LJ; Cherrington BD; Palmer AM; Howe LR; Subramanian V; Causey CP; Thompson PR; Gray JW; Coonrod SA
BMC Cancer; 2012 Oct; 12():500. PubMed ID: 23110523
[TBL] [Abstract][Full Text] [Related]
20. Alkylaminophenol and GPR17 Agonist for Glioblastoma Therapy: A Combinational Approach for Enhanced Cell Death Activity.
Doan P; Nguyen P; Murugesan A; Candeias NR; Yli-Harja O; Kandhavelu M
Cells; 2021 Aug; 10(8):. PubMed ID: 34440745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
